Accès gratuit
Numéro
Réanimation
Volume 25, Numéro 4, Juillet 2016
Médecine interne et transversalité
Page(s) 408 - 418
Section Mise au Point / Update
DOI https://doi.org/10.1007/s13546-016-1211-6
Publié en ligne 15 juin 2016
  • Bureau C, Pagan JCG, Layrargues GP, et al (2007) Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27:742–7 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M (2013) TIPS: 25 years later. J Hepatol 59:1081–93 [CrossRef] [PubMed] [Google Scholar]
  • Bureau C, García-Pagán JC, Otal P, et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126:469–75 [CrossRef] [PubMed] [Google Scholar]
  • Yang Z, Han G, Wu Q, et al (2010) Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents vs bare stents: a meta-analysis. J Gastroenterol Hepatol 25:1718–25 [CrossRef] [PubMed] [Google Scholar]
  • Luca A, Miraglia R, Caruso S, et al (2011) Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 60:846–52 [CrossRef] [PubMed] [Google Scholar]
  • Perarnau JM, Le Gouge A, Nicolas C, et al (2014) Covered vs uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol 60:962–8 [CrossRef] [PubMed] [Google Scholar]
  • Riggio O, Ridola L, Angeloni S, et al (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53:267–72 [CrossRef] [PubMed] [Google Scholar]
  • Xiao T, Chen L, Chen W, et al (2011) Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone vs TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol 45:643–50 [CrossRef] [PubMed] [Google Scholar]
  • Tesdal IK, Filser T, Weiss C, et al (2005) Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 236:360–7 [CrossRef] [PubMed] [Google Scholar]
  • Shi Y, Tian X, Hu J, et al (2014) Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci 59:2325–32 [CrossRef] [PubMed] [Google Scholar]
  • Chen S, Li X, Wei B, et al (2013) Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 268:900–6 [CrossRef] [PubMed] [Google Scholar]
  • Fidelman N, Kwan SW, LaBerge JM, et al (2012) The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol 199:746–55 [CrossRef] [PubMed] [Google Scholar]
  • Bouza E, Muñoz P, Rodríguez C, et al (2004) Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension. Diagn Microbiol Infect Dis 49:77–82 [CrossRef] [Google Scholar]
  • Deibert P, Schwarz S, Olschewski M, et al (1998) Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: results of a randomized study. Dig Dis Sci 43:1708–13 [CrossRef] [PubMed] [Google Scholar]
  • Gulberg V, Deibert P, Ochs A, et al (1999) Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone. Hepatogastroenterology 46:1126–30 [PubMed] [Google Scholar]
  • Sutcliffe JA, Briggs JH, Little MW, et al (2015) Antibiotics in interventional radiology. Clin Radiol 70:223–34 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M, Euringer W (2012) Hepatic encephalopathy in patients with transjugular intrahepatic portosystemic shunt (TIPS). Clin Gastroenterol 211–20 [Google Scholar]
  • Jalan R, Elton RA, Redhead DN, et al (1995) Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23:123–8 [CrossRef] [PubMed] [Google Scholar]
  • Somberg KA, Riegler JL, LaBerge JM, et al (1995) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 90:549–55 [PubMed] [Google Scholar]
  • Sanyal AJ, Freedman AM, Shiffman ML, et al (1994) Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20:46–55 [PubMed] [Google Scholar]
  • Malinchoc M, Kamath PS, Gordon FD, et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–71 [CrossRef] [PubMed] [Google Scholar]
  • Bureau C, Métivier S, D’Amico M, et al (2011) Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 54:901–7 [CrossRef] [PubMed] [Google Scholar]
  • Rabie RN, Cazzaniga M, Salerno F, et al (2009) The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 104:2458–66 [CrossRef] [PubMed] [Google Scholar]
  • Cazzaniga M, Salerno F, Pagnozzi G, et al (2007) Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 56:869–75 [CrossRef] [PubMed] [Google Scholar]
  • Albillos A, Bañares R, González M, et al (2005) A meta-analysis of transjugular intrahepatic portosystemic shunt vs paracentesis for refractory ascites. J Hepatol 43:990–6 [CrossRef] [PubMed] [Google Scholar]
  • García-Pagán JC, Caca K, Bureau C, et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–9 [CrossRef] [PubMed] [Google Scholar]
  • Salerno F, Cammà C, Enea M, et al (2007) Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133:825–34 [CrossRef] [PubMed] [Google Scholar]
  • Moitinho E, Escorsell A, Bandi JC, et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–31 [CrossRef] [PubMed] [Google Scholar]
  • Bañares R, Casado M, Rodríguez-Láiz JM, et al (1998) Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 93:75–9 [CrossRef] [PubMed] [Google Scholar]
  • Chau TN, Patch D, Chan YW, et al (1998) « Salvage » transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114:981–7 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay D, Castaing D, Majno P, et al (2001) Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–7 [CrossRef] [PubMed] [Google Scholar]
  • De Franchis R (2015) Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743–52 [CrossRef] [PubMed] [Google Scholar]
  • Holster IL, Tjwa ETTL, Moelker A, et al (2016) Covered transjugular intrahepatic portosystemic shunt vs endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology 63:581–9 [CrossRef] [PubMed] [Google Scholar]
  • Sauerbruch T, Mengel M, Dollinger M, et al (2015) Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs hemodynamically controlled medical therapy. Gastroenterology 149:660–8 [CrossRef] [PubMed] [Google Scholar]
  • Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793–801 [CrossRef] [PubMed] [Google Scholar]
  • Barange K, Péron JM, Imani K, et al (1999) Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 30:1139–43 [CrossRef] [PubMed] [Google Scholar]
  • Mahadeva S, Bellamy MC, Kessel D, et al (2003) Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections vs transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 98:2688–93 [CrossRef] [PubMed] [Google Scholar]
  • Lo GH (2014) Controlled trial of TIPS vs cyanoacrylate glue for gastric variceal bleeding. Gastrointest Endosc 79:182 [PubMed] [Google Scholar]
  • Mezawa S, Homma H, Ohta H, et al (2001) Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 96:1155–9 [CrossRef] [PubMed] [Google Scholar]
  • Spahr L, Villeneuve JP, Dufresne MP, et al (1999) Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44:739–42 [CrossRef] [PubMed] [Google Scholar]
  • Rössle M, Gerbes AL (2010) TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 59:988–1000 [CrossRef] [PubMed] [Google Scholar]
  • Dhanasekaran R, West JK, Gonzales PC, et al (2010) Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 105:635–41 [CrossRef] [PubMed] [Google Scholar]
  • Siegerstetter V, Deibert P, Ochs A, et al (2001) Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 13:529–34 [CrossRef] [PubMed] [Google Scholar]
  • Michl P, Gülberg V, Bilzer M, et al (2000) Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand J Gastroenterol 35:654–8 [CrossRef] [PubMed] [Google Scholar]
  • Wong F, Pantea L, Sniderman K (2004) Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40:55–64 [CrossRef] [PubMed] [Google Scholar]
  • Brensing KA, Textor J, Perz J, et al (2000) Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47:288–95 [CrossRef] [PubMed] [Google Scholar]
  • Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35:1179–85 [CrossRef] [PubMed] [Google Scholar]
  • Guerrini GP, Pleguezuelo M, Maimone S, et al (2009) Impact of tips preliver transplantation for the outcome posttransplantation. Am J Transplant 9:192–200 [CrossRef] [PubMed] [Google Scholar]
  • Testino G, Leone S, Ferro C, et al (2012) Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt. J Med Life 5:203–5 [PubMed] [Google Scholar]
  • García-Pagán JC, Heydtmann M, Raffa S, et al (2008) TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 135:808–15 [CrossRef] [PubMed] [Google Scholar]
  • Bhangui P, Laurent A, Amathieu R, et al (2012) Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol 57:874–84 [CrossRef] [PubMed] [Google Scholar]
  • Teh SH, Nagorney DM, Stevens SR, et al (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132:1261–9 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay D, Buabse F, Damiano I, et al (2001) Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 193:46–51 [CrossRef] [PubMed] [Google Scholar]
  • Menahem B, Lubrano J, Desjouis A, et al (2015) Transjugular intrahepatic portosystemic shunt placement increases feasability of colorectal surgery in cirrhotic patients with severe portal hypertension. Dig Liv Dis 47:81–4 [CrossRef] [Google Scholar]
  • Vinet E, Perreault P, Bouchard L, et al (2006) Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study. Can J Gastroenterol 20:401–4 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.